Optimizing Resin Performance with Disposable Chromatography Solutions
Although the initial uptake of single-use chromatography solutions has been relatively slow, an increased need for higher-capacity resins and the demand for smaller batches has made disposable chromatography a more viable option.
Read this article from BioPharm International’s 2014 Secure Single-Use Systems eBook.
View other articles in the 2014 Secure Single-Use Systems eBook.
|
|---|
|
Current Issue
Wearable Injection Devices Address Delivery Challenges
Advances in wearable devices have made it possible to deliver high-volume, high-viscosity biologics.
When One Therapy No Longer Fits All
More diversified therapies and tighter payer budgets will challenge bio/pharma companies to think outside the industry.
Outsourcing Analytical Processes in Biologics Development
Outsourcing analytics can be a cost-effective way for biopharma companies to adapt to new technologies and regulations.
Outsourcing
Catalent Adds Clinical Supplies Capacity
A $5.5-million expansion at its Philadelphia, PA clinical supplies facility gives Catalent additional packaging and storage capacity.
Cost Cutting to Drive 12% Growth in CRO Outsourcing Through 2021, New Study Finds
A new study by the Business Research Company reveals prominent contract research organization outsourcing trends.
New Jersey Firm Gets FDA Warning Letter
FDA sent a warning letter to Tris Pharma Inc. after investigators found the company had failed to properly investigate batch failures and establish quality control procedures.
Outsourcing Analytical Processes in Biologics Development
Outsourcing analytics can be a cost-effective way for biopharma companies to adapt to new technologies and regulations.
Standards/Regulations
EMA and the Netherlands Finalize Seat Agreement
EMA and its new host country have finalized the terms of the agency’s relocation to Amsterdam.
CDER Publishes Drug Safety Report
FDA’s Center for Drug Evaluation and Research has published its second annual report on key safety programs and activities.
FDA Seeks to Advance Treatments for Opioid Use Disorder
The agency has released new guidance on the development of new medication-assisted treatments for opioid dependence.
Sponsored Links
